ArticleJournal of experimental & clinical cancer research : CR2022

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.

Ming Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.